- Home
- HUT vs APGE Comparison
HUT vs APGE Comparison
Compare HUT & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUT
- APGE
- Stock Information
- Founded
- HUT 2011
- APGE 2022
- Country
- HUT United States
- APGE United States
- Employees
- HUT N/A
- APGE N/A
- Industry
- HUT Finance: Consumer Services
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HUT Finance
- APGE Health Care
- Exchange
- HUT Nasdaq
- APGE Nasdaq
- Market Cap
- HUT 2.2B
- APGE 2.0B
- IPO Year
- HUT N/A
- APGE 2023
- Fundamental
- Price
- HUT $23.32
- APGE $37.29
- Analyst Decision
- HUT Strong Buy
- APGE Strong Buy
- Analyst Count
- HUT 14
- APGE 4
- Target Price
- HUT $27.36
- APGE $97.50
- AVG Volume (30 Days)
- HUT 4.5M
- APGE 576.9K
- Earning Date
- HUT 08-07-2025
- APGE 08-11-2025
- Dividend Yield
- HUT N/A
- APGE N/A
- EPS Growth
- HUT N/A
- APGE N/A
- EPS
- HUT 1.48
- APGE N/A
- Revenue
- HUT $138,543,000.00
- APGE N/A
- Revenue This Year
- HUT $74.79
- APGE N/A
- Revenue Next Year
- HUT $116.78
- APGE N/A
- P/E Ratio
- HUT $15.74
- APGE N/A
- Revenue Growth
- HUT N/A
- APGE N/A
- 52 Week Low
- HUT $8.73
- APGE $26.20
- 52 Week High
- HUT $31.95
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- HUT 62.22
- APGE 46.88
- Support Level
- HUT $21.32
- APGE $36.74
- Resistance Level
- HUT $21.71
- APGE $38.92
- Average True Range (ATR)
- HUT 1.44
- APGE 1.78
- MACD
- HUT 0.24
- APGE 0.07
- Stochastic Oscillator
- HUT 88.89
- APGE 53.44
About HUT Hut 8 Corp.
Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.